KMT2A and leukemia: Nonetheless, several groups have developed small molecule inhibitors that disrupt the interaction between MLL1 and Menin and have shown in vitro and in vivo impairment of leukemia growth and proliferation, irrespective of the MLL fusion partner (234–237).